Pipeline & Development Strategy

Our company is advancing a programmable long-acting therapeutic platform through a staged development strategy designed to support clinical translation:

 

1) Platform validation:
 

Our primary focus is the development and translational validation of our therapeutic platform as a standalone system. Current work is aimed at generating the preclinical package needed to support future clinical development.

​

2) Indication strategy
 

In parallel, we are evaluating focused disease applications where the platform may offer a clinically efficient path to proof of concept. Among these, muscle atrophy-related orphan indications represent a potential opportunity for accelerated development.
 

3) Future expansion

Once the platform is validated, its modular design may enable expansion across multiple payloads and therapeutic areas.